Home/Filings/4/0001865504-25-000010
4//SEC Filing

Glaser Shelagh 4

Accession 0001865504-25-000010

CIK 0000883241other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:38 PM ET

Size

13.1 KB

Accession

0001865504-25-000010

Insider Transaction Report

Form 4
Period: 2025-12-19
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-19$354.45/sh+1,044$370,04618,886 total
  • Sale

    Common Stock

    2025-12-19$460.77/sh1,044$481,04417,842 total
  • Exercise/Conversion

    Common Stock

    2025-12-19$348.17/sh+2,613$909,76820,455 total
  • Sale

    Common Stock

    2025-12-19$460.77/sh2,613$1,203,99217,842 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-12-192,61310,448 total
    Exercise: $348.17From: 2023-12-02Exp: 2029-12-02Common Stock (2,613 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-12-191,0445,365 total
    Exercise: $354.45From: 2024-02-17Exp: 2030-02-17Common Stock (1,044 underlying)
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2025.
  • [F2]1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Issuer

SYNOPSYS INC

CIK 0000883241

Entity typeother

Related Parties

1
  • filerCIK 0001865504

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:38 PM ET
Size
13.1 KB